|
V53290
|
Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) |
1678417-57-6 |
Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) is a 29-amino acid (AA) chimeric peptide synthesized by adding a nonylarginine motif to the carboxyl terminus of rabies virus glycoprotein (RVG). |
|
V54357
|
Docaravimab |
2247196-23-0 |
Docaravimab is an antibody that targets epitope G-III of the extracellular domain of the ERA (Evelyn-Rockitniki-Abelseth) glycoprotein. |
|
V52087
|
Foravirumab (CR4098) |
944548-38-3 |
Foravirumab (CR4098) is a monoclonal antibody (mAb) targeting antigenic site III of the rabies virus glycoprotein and may be utilized in rabies research. |
|
V2214
|
GRP 60367 |
1309241-34-6 |
GRP 60367 is a novel,potent and selective rabies virus (RABV) entry inhibitor with nanomolar potency against some RABV strains. |
|
V52042
|
GRP-60367 hydrochloride |
2803211-60-9 |
GRP-60367 HCl is a first-in-class small molecule rabies virus (RABV) entry inhibitor (antagonist) with nanomolar effects against certain RABV strains. |
|
V51806
|
Mazorelvimab (SYN023) |
2419087-89-9 |
Mazorelvimab (SYN023) is a hybrid anti-rabies virus (RABV) humanized monoclonal antibody (mAb) consisting of CTB011 and CTB012. |
|
V54358
|
Ormutivimab (NM57; rhRIG) |
2449086-91-1 |
Ormutivimab (rhRIG) is a recombinant human monoclonal antibody (mAb) targeting rabies virus. |
|
V81272
|
Rabies Virus Glycoprotein |
|
Rabies Virus Glycoprotein is a cell-penetrable peptide consisting of 29 amino acid (AA) residues, derived from rabies virus glycoprotein, which can cross the BBB (blood-brain barrier) and enter brain cells. |
|
V76569
|
Rabies Virus Glycoprotein TFA |
|
Rabies Virus Glycoprotein (TFA) is a cell-penetrable peptide consisting of 29 amino acid (AA) residues, derived from rabies virus glycoprotein, which can cross the BBB (blood-brain barrier) and enter brain cells. |
|
V39200
|
Rafivirumab (CR57) |
944548-37-2 |
Rafivirumab (CR57) is an anti-rabies virus monoclonal antibody (mAb) used to prevent rabies. |
|
V35104
|
Zamerovimab (CTB011; SYN023) |
2419087-87-7 |
Zamerovimab (CTB011; SYN023) is a humanized monoclonal antibody (mAb) cocktail consisting of CTB011 and CTB012. |